BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22706990)

  • 1. Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09.
    Huyton T; Schumacher H; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2012 Sep; 64(9):663-8. PubMed ID: 22706990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P.
    Bade-Doeding C; Cano P; Huyton T; Badrinath S; Eiz-Vesper B; Hiller O; Blasczyk R
    Hum Immunol; 2011 Nov; 72(11):1039-44. PubMed ID: 21872626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.
    Bade-Doeding C; DeLuca DS; Seltsam A; Blasczyk R; Eiz-Vesper B
    Immunogenetics; 2007 Apr; 59(4):253-9. PubMed ID: 17294180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes.
    Badrinath S; Saunders P; Huyton T; Aufderbeck S; Hiller O; Blasczyk R; Bade-Doeding C
    Haematologica; 2012 Jan; 97(1):98-106. PubMed ID: 21993680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The composition of the F pocket in HLA-A*74 generates C-terminal promiscuity among its bound peptides.
    Bade-Doeding C; Huyton T; Eiz-Vesper B; Blasczyk R
    Tissue Antigens; 2011 Nov; 78(5):378-81. PubMed ID: 21762397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the PΩ peptide motif.
    Elamin NE; Bade-Doeding C; Blasczyk R; Eiz-Vesper B
    Tissue Antigens; 2010 Dec; 76(6):487-90. PubMed ID: 20707881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position 45 influences the peptide binding motif of HLA-B*44:08.
    Badrinath S; Huyton T; Schumacher H; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2012 Mar; 64(3):245-9. PubMed ID: 22009320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pocketcheck: updating the HLA class I peptide specificity roadmap.
    Huyton T; Ladas N; Schumacher H; Blasczyk R; Bade-Doeding C
    Tissue Antigens; 2012 Sep; 80(3):239-48. PubMed ID: 22803829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.
    Manandhar T; Kunze-Schumacher H; Huyton T; Celik AA; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2016 Apr; 68(4):247-60. PubMed ID: 26758079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling between side chain interactions and binding pocket flexibility in HLA-B*44:02 molecules investigated by molecular dynamics simulations.
    Ostermeir K; Springer S; Zacharias M
    Mol Immunol; 2015 Feb; 63(2):312-9. PubMed ID: 25146482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.
    DiBrino M; Parker KC; Margulies DH; Shiloach J; Turner RV; Biddison WE; Coligan JE
    Biochemistry; 1995 Aug; 34(32):10130-8. PubMed ID: 7543776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
    Eichmann M; de Ru A; van Veelen PA; Peakman M; Kronenberg-Versteeg D
    Tissue Antigens; 2014 Oct; 84(4):378-88. PubMed ID: 25154780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.
    Chow IT; James EA; Tan V; Moustakas AK; Papadopoulos GK; Kwok WW
    Mol Immunol; 2012 Feb; 50(1-2):26-34. PubMed ID: 22196942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of peptides presented by an HLA class I low expression allele.
    Hinrichs J; Föll D; Bade-Döding C; Huyton T; Blasczyk R; Eiz-Vesper B
    Haematologica; 2010 Aug; 95(8):1373-80. PubMed ID: 20220067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico analysis of peptide binding features of HLA-B*4006.
    Gadewal NS; Joshi NN
    Indian J Exp Biol; 2012 Feb; 50(2):93-100. PubMed ID: 22670471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide binding specificities of HLA-B*5701 and B*5801.
    Zhang Y; Mei H; Wang Q; Xie J; Lv J; Pan X; Tan W
    Sci China Life Sci; 2012 Sep; 55(9):818-25. PubMed ID: 23015131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural definition of the H-2Kd peptide-binding motif.
    Mitaksov V; Fremont DH
    J Biol Chem; 2006 Apr; 281(15):10618-25. PubMed ID: 16473882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling.
    James EA; Moustakas AK; Berger D; Huston L; Papadopoulos GK; Kwok WW
    Mol Immunol; 2008 May; 45(9):2651-9. PubMed ID: 18276010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of the Endogenous Peptidomes Displayed by HLA-B*27 and Mamu-B*08: Two MHC Class I Alleles Associated with Elite Control of HIV/SIV Infection.
    Marcilla M; Alvarez I; Ramos-Fernández A; Lombardía M; Paradela A; Albar JP
    J Proteome Res; 2016 Mar; 15(3):1059-69. PubMed ID: 26811146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.